AbCellera Biologics Inc. ABCL
11.13 USD -1.15 (-9.36%)
At closeNov 6, 2026, 6:17 AM EST
11.32 +0.19 +1.71%
Pre-market · Nov 6, 6:17 AM ET
10.76 Day range 11.88
2.75 52-week range 15.02
- YTD
- +225.44%
- 1 year
- +137.31%
Financial health
Altman Z-Score
5.24 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 3
Valuation
P/E -7.0×
FY 2018 5y median -5.3× FY 2025
P/S 13.6×
FY 2018 5y median 13.6× FY 2025
P/B 1.1×
FY 2018 5y median 1.4× FY 2025
P/FCF -5.9×
FY 2018 5y median -4.6× FY 2025
EV/EBITDA -7.0×
FY 2018 5y median -3.8× FY 2025
EV/Sales 13.8×
FY 2018 5y median 13.8× FY 2025
FCF Yield -17.0%
FY 2018 5y median -7.4% FY 2025
Profitability
Gross Margin 61.6%
FY 2018 5y median 87.9% FY 2025
Operating Margin -289.0%
FY 2018 5y median -289.0% FY 2025
Net Margin -194.9%
FY 2018 5y median -194.9% FY 2025
ROE -15.1%
FY 2018 5y median -12.7% FY 2025
ROIC -13.8%
FY 2018 5y median -13.8% FY 2025
ROA -10.8%
FY 2018 5y median -9.8% FY 2025
Growth (YoY)
Revenue 160.6%
FY 2018 FY 2025
Operating Income 31.0%
FY 2018 FY 2025
EPS (diluted) 10.9%
FY 2018 FY 2025
Free Cash Flow 6.9%
FY 2018 FY 2025
Financial Health
Current Ratio 11.3×
FY 2018 5y median 8.7× FY 2025
Quick Ratio 11.2×
FY 2018 5y median 8.7× FY 2025
Debt / Equity 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA -0.1×
FY 2018 5y median -0.1× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
